- Home
- TXMD vs MTR Comparison
TXMD vs MTR Comparison
Compare TXMD & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- MTR
- Stock Information
- Founded
- TXMD 2008
- MTR 1979
- Country
- TXMD United States
- MTR United States
- Employees
- TXMD N/A
- MTR N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- TXMD Health Care
- MTR Energy
- Exchange
- TXMD Nasdaq
- MTR Nasdaq
- Market Cap
- TXMD 12.8M
- MTR 12.6M
- IPO Year
- TXMD N/A
- MTR N/A
- Fundamental
- Price
- TXMD $1.00
- MTR $6.72
- Analyst Decision
- TXMD
- MTR
- Analyst Count
- TXMD 0
- MTR 0
- Target Price
- TXMD N/A
- MTR N/A
- AVG Volume (30 Days)
- TXMD 113.1K
- MTR 12.5K
- Earning Date
- TXMD 03-28-2025
- MTR 01-01-0001
- Dividend Yield
- TXMD N/A
- MTR 2.90%
- EPS Growth
- TXMD N/A
- MTR N/A
- EPS
- TXMD N/A
- MTR 0.35
- Revenue
- TXMD $1,596,000.00
- MTR $966,169.00
- Revenue This Year
- TXMD $605.07
- MTR N/A
- Revenue Next Year
- TXMD $1.11
- MTR N/A
- P/E Ratio
- TXMD N/A
- MTR $19.36
- Revenue Growth
- TXMD N/A
- MTR N/A
- 52 Week Low
- TXMD $0.70
- MTR $5.60
- 52 Week High
- TXMD $2.75
- MTR $11.99
- Technical
- Relative Strength Index (RSI)
- TXMD 41.47
- MTR 49.57
- Support Level
- TXMD $0.99
- MTR $7.05
- Resistance Level
- TXMD $1.13
- MTR $7.30
- Average True Range (ATR)
- TXMD 0.06
- MTR 0.29
- MACD
- TXMD -0.00
- MTR -0.02
- Stochastic Oscillator
- TXMD 5.26
- MTR 34.89
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.